The S1 site (Asp 189 ) of factor Xa (fXa) is located on a loop (residues 185-189) that contains three solvent-exposed charged residues (Asp 185 , Lys 186 , and Glu 188 ) below the active-site pocket of the protease. To investigate the role of these residues in the catalytic function of fXa, we expressed three mutants of the protease in which the charges of these residues were neutralized by their substitutions with Ala (D185A, K186A, and E188A). Kinetic studies revealed that E188A has a normal catalytic activity toward small synthetic and natural substrates and inhibitors of fXa; however, the same activities were slightly (ϳ2-fold) and dramatically (ϳ20 -50-fold) impaired for the D185A and K186A mutants, respectively. Further studies revealed that the affinity of D185A and K186A for interaction with Na ؉ has also been altered, with a modest impairment (ϳ2-fold) for the former and a dramatic impairment for the latter mutant. Both prothrombinase and direct binding studies indicated that K186A also has an ϳ6-fold impaired affinity for factor Va. Interestingly, a saturating concentration of factor Va restored the catalytic defect of K186A in reactions with prothrombin and the recombinant tick anticoagulant peptide that is known to interact with the Na ؉ loop of fXa, but not with other substrates. These results suggest that factor Va interacts with 185-189-loop for fXa, which is energetically linked to the Na ؉ -binding site of the protease.Factor X is a vitamin-K dependent serine protease zymogen in plasma that upon activation to factor Xa (fXa) 1 forms a high affinity complex with other components of the prothrombinase complex (factor Va, negatively charged phospholipid vesicles, and calcium) to activate prothrombin to thrombin during the blood coagulation process (1-5). The catalytic efficiency of fXa in the prothrombinase complex is five orders of magnitude higher than that of fXa alone (1, 2). Most of the accelerating effect of the prothrombinase complex assembly is attributed to the cofactor function of factor Va (fVa), which can bind to and alter the kinetic properties of fXa by inducing conformational changes in the structure of the protease and also by providing secondary binding sites for the substrate prothrombin in the activation complex (6 -10). The molecular details of the fXa interaction with fVa have not been fully elucidated. However, recent results have indicated that the mutagenesis of the basic residues of the heparin binding 162-helix on the protease domain (especially Arg 165 in the chymotrypsinogen numbering system (11)) dramatically impairs the ability of fXa to interact with fVa in the prothrombinase complex (12). In addition to the 162-helix, other basic residues of the heparin binding site of fXa have been implicated in fVa binding (12, 13); however, the exact contribution of these residues to the recognition mechanism of the protease-cofactor interaction has not been studied in detail.Similar to other coagulation proteases, fXa is an allosteric enzyme, and thus the binding of metal ions an...